SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TEBALDI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.873
AS - Asia 3.018
EU - Europa 1.599
SA - Sud America 488
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 10.053
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.752
SG - Singapore 1.213
CN - Cina 671
DE - Germania 386
BR - Brasile 382
IT - Italia 327
VN - Vietnam 319
HK - Hong Kong 245
FI - Finlandia 214
GB - Regno Unito 134
BD - Bangladesh 133
FR - Francia 121
UA - Ucraina 104
TR - Turchia 100
JP - Giappone 75
IN - India 73
SE - Svezia 71
RU - Federazione Russa 67
CA - Canada 57
ID - Indonesia 57
PL - Polonia 53
MX - Messico 46
NL - Olanda 38
AR - Argentina 32
ZA - Sudafrica 31
IQ - Iraq 27
EC - Ecuador 24
CO - Colombia 17
ES - Italia 17
AT - Austria 14
LT - Lituania 12
PH - Filippine 12
PK - Pakistan 11
BE - Belgio 10
VE - Venezuela 10
MY - Malesia 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
NP - Nepal 7
CL - Cile 6
MA - Marocco 6
IE - Irlanda 5
PE - Perù 5
UY - Uruguay 5
CH - Svizzera 4
EG - Egitto 4
ET - Etiopia 4
IR - Iran 4
KR - Corea 4
KZ - Kazakistan 4
PY - Paraguay 4
AU - Australia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
IL - Israele 3
JM - Giamaica 3
KG - Kirghizistan 3
KW - Kuwait 3
MD - Moldavia 3
NI - Nicaragua 3
SN - Senegal 3
TN - Tunisia 3
TW - Taiwan 3
AM - Armenia 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
EU - Europa 1
GH - Ghana 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MW - Malawi 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
Totale 10.043
Salva come PNG Salva come JPEG
Città #
Ashburn 740
Singapore 711
San Jose 415
Fairfield 387
Woodbridge 311
Munich 250
Hong Kong 241
Beijing 235
Santa Clara 235
Houston 194
Chandler 174
Helsinki 139
Seattle 138
Wilmington 127
Cambridge 122
Ho Chi Minh City 114
Jacksonville 113
New York 109
Ann Arbor 105
Los Angeles 94
Dallas 90
Tokyo 75
Hanoi 64
Princeton 61
Lauterbourg 54
Council Bluffs 52
Jakarta 52
Izmir 51
Shanghai 49
Milan 47
San Diego 47
São Paulo 47
Warsaw 47
Nanjing 40
Ferrara 39
Turku 38
London 36
Chicago 28
Mexico City 28
Brooklyn 27
Orem 25
Buffalo 24
Chennai 23
Atlanta 22
Bologna 19
Bremen 19
Frankfurt am Main 18
Toronto 18
Boardman 17
Denver 17
Johannesburg 17
San Francisco 17
Stockholm 17
Boston 16
Haiphong 15
Montreal 14
Moscow 14
Tianjin 14
Nanchang 13
Nuremberg 13
Da Nang 12
Amsterdam 11
Augusta 11
Falls Church 11
Phoenix 11
Rio de Janeiro 11
Rome 11
Brussels 10
Charlotte 10
The Dalles 10
Dong Ket 9
Jyväskylä 9
Lappeenranta 9
Salt Lake City 9
Ankara 8
Dhaka 8
Falkenstein 8
Jiaxing 8
Mumbai 8
Quito 8
Shenyang 8
Tashkent 8
Changsha 7
Goiânia 7
Hebei 7
Hefei 7
Hải Dương 7
Kathmandu 7
Ninh Bình 7
Norwalk 7
Washington 7
Baghdad 6
Brasília 6
Campinas 6
City of London 6
Des Moines 6
Hangzhou 6
Mountain View 6
Nairobi 6
Perugia 6
Totale 6.603
Salva come PNG Salva come JPEG
Nome #
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 421
Poor response to clopidogrel: current and future options for its management 291
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 289
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 280
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 244
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 235
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 235
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 227
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 225
Angina and left ventricular dysfunction: can we "reduce' it? 225
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 214
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 212
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 204
Fractional flow reserve: Current applications and overview of the available data 199
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 197
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 196
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 193
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 190
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 189
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment 189
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 188
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 186
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) 185
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 185
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 181
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 180
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 179
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 177
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 174
Fractional flow reserve implementation in daily clinical practice: A European survey 170
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 170
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 168
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 166
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 163
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 162
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? 158
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 157
Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study 155
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 154
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 146
Enhanced stent visualization systems during PCI: A case series and review of literature 144
Seven french radial artery access for PCI: A prospective single-center experience 135
Functional Assessment and Acute Coronary Syndrome 133
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 128
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 121
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. 116
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 116
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction 114
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 113
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review 110
Comment on [Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease] 105
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 101
null 94
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 91
Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine 91
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial 90
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial 87
Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study 85
Quantitative flow ratio as a new tool for angiography-based physiological evaluation of coronary artery disease: a review 77
Low FFR equal to low ischemia: Really? 61
The unbearable lightness of the instantaneous wave-free ratio/fractional flow reserve discordance 54
Totale 10.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.495
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/2022624 86 57 52 28 21 34 34 43 16 40 66 147
2022/2023471 59 23 36 27 74 62 25 49 66 6 32 12
2023/2024439 24 34 18 15 30 85 23 80 6 15 8 101
2024/20251.981 25 36 130 82 206 219 164 137 369 176 254 183
2025/20264.674 446 213 388 498 662 266 474 239 497 524 280 187
Totale 10.225